Medpace Holdings, Inc. balance sheet
At the end of fiscal 2025, Medpace Holdings, Inc. had total assets of $1.98bn, total liabilities of $1.52bn and shareholders' equity of $459m. It held $497m in cash against $0 of debt: net cash of $497m.
Balance sheet
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15 | 37 | 26 | 23 | 132 | 278 | 461 | 28 | 245 | 669 | 497 | 705 |
| Receivables | 65 | 80 | 83 | 133 | 156 | 161 | 186 | 253 | 298 | 296 | 402 | 448 |
| Total current assets | 95 | 133 | 130 | 178 | 317 | 474 | 691 | 334 | 594 | 1,029 | 990 | 1,245 |
| Goodwill | 661 | 661 | 661 | 661 | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 |
| Total assets | 984 | 979 | 951 | 1,005 | 1,143 | 1,391 | 1,660 | 1,352 | 1,657 | 2,101 | 1,975 | 2,303 |
| Accounts payable | 9 | 11 | 17 | 17 | 22 | 27 | 26 | 33 | 32 | 33 | 28 | 44 |
| Deferred revenue (current) | 51 | 66 | 74 | 148 | 192 | 256 | 345 | 463 | 560 | 711 | 854 | 962 |
| Total current liabilities | 134 | 169 | 193 | 263 | 343 | 440 | 557 | 803 | 925 | 1,105 | 1,344 | 1,496 |
| Short-term debt | 0 | 12 | 17 | 0 | — | — | 0 | 50 | 0 | — | — | — |
| Long-term debt | 378 | 151 | 205 | 80 | 0 | — | — | — | — | — | — | — |
| Total debt | 390 | 165 | 223 | 80 | 0 | 0 | 0 | 50 | 0 | 0 | 0 | 0 |
| Total liabilities | 571 | 368 | 447 | 406 | 417 | 585 | 707 | 966 | 1,098 | 1,275 | 1,516 | 1,718 |
| Shareholders' equity | 413 | 611 | 509 | 599 | 726 | 806 | 953 | 386 | 559 | 826 | 459 | 585 |
| Net debt (negative = net cash) | 375 | 128 | 196 | 56 | −132 | −278 | −461 | 22 | −245 | −669 | −497 | −705 |
| Shares outstanding | 33m | 41m | 35m | 36m | 36m | 36m | 36m | 31m | 31m | 31m | 28m | 28m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 296 | 298 | 378 | 373 | 402 | 395 | 442 | 448 |
| Total current assets | 1,029 | 821 | 521 | 737 | 990 | 1,139 | 1,050 | 1,245 |
| Goodwill | 662 | 662 | 662 | 662 | 662 | 662 | 662 | 662 |
| Total assets | 2,101 | 1,897 | 1,572 | 1,753 | 1,975 | 2,130 | 2,057 | 2,303 |
| Accounts payable | 33 | 61 | 43 | 27 | 28 | 34 | 38 | 44 |
| Deferred revenue (current) | 711 | 719 | 809 | 834 | 854 | 856 | 905 | 962 |
| Total current liabilities | 1,105 | 1,122 | 1,220 | 1,284 | 1,344 | 1,345 | 1,435 | 1,496 |
| Total liabilities | 1,275 | 1,304 | 1,399 | 1,459 | 1,516 | 1,531 | 1,623 | 1,718 |
| Shareholders' equity | 826 | 594 | 172 | 294 | 459 | 598 | 434 | 585 |
| Shares outstanding | 31m | 30m | 28m | 28m | 28m | 29m | 28m | 28m |
Compare with peers
- Fortrea Holdings Inc. balance sheet
- Bio-rad Laboratories, Inc. balance sheet
- Bruker Corp balance sheet
- Qiagen N.V. balance sheet
- Charles River Laboratories balance sheet
Head to head: FTRE vs MEDPBIO vs MEDPBRKR vs MEDPMEDP vs QGEN
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies